| Literature DB >> 31711985 |
Erfei Luo1, Dong Wang2, Gaoliang Yan3, Yong Qiao4, Boqian Zhu5, Bo Liu6, Jiantong Hou7, Chengchun Tang8.
Abstract
Endothelial cells (ECs) primarily rely on glycolysis for their energy metabolism, and the final product of glycolysis-lactate-is transferred out of cells via monocarboxylate transporter 4 (MCT4). We previously showed that MCT4 downregulation is involved in diabetic endothelial injury. However, the underlying regulatory mechanisms of MCT4 in diabetes remain unclear. This study showed that miR-425-5p was significantly upregulated in diabetic patients and human umbilical vein endothelial cells (HUVECs) treated with high glucose (HG) and interleukin-1β (IL-1β). MCT4 was shown to be a direct target gene of miR-425-5p, and miR-425-5p expression led to MCT4 downregulation, lactate accumulation and increased apoptosis in HUVECs. Furthermore, the results indicated that NF-κB signaling activation increased miR-425-5p levels and induced MCT4 downregulation, lactate accumulation and apoptosis in HUVECs. In conclusion, NF-κB/miR-425-5p/MCT4 axis activation plays a crucial role in the EC injury induced by HG and IL-1β.Entities:
Keywords: Diabetes mellitus; Endothelial dysfunction; Monocarboxylate transporter 4; NF-κB; miR-425-5p
Year: 2019 PMID: 31711985 DOI: 10.1016/j.mce.2019.110641
Source DB: PubMed Journal: Mol Cell Endocrinol ISSN: 0303-7207 Impact factor: 4.102